8:30am - 6:30pm [EDT]
IAS – the International AIDS Society – through its Towards an HIV Cure programme, organised the annual HIV cure meeting just before AIDS 2022, the 24th International AIDS Conference, as an Affiliated Independent Event. The hybrid meeting was organised in partnership with the Canadian HIV Cure Enterprise (CanCURE) and the FRQS - AIDS and Infectious Diseases Research Network. It took place in person at the Centre Hospitalier de l'Université de Montréal (CHUM) and virtually on 28 July 2022.
The meeting programme was designed to reflect the “Research priorities for an HIV cure: IAS Global Scientific Strategy 2021”, published in Nature Medicine. The sessions highlighted cure advances globally and promising research strategies while translating the latest science and incorporating diverse perspectives on HIV cure.
You can access all the meeting materials using the links below:
- Pathways to an HIV cure: Research and advocacy priorities - Welcome!
- IAS Global Scientific Strategy 2021 - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia
- The science in context: a community perspective - Simon Collins, i-Base, UK
- Berlin, London, Dusseldorf and New York Patients - Kumitaa Theva Das, Universiti Sains Malaysia, Malaysia
- HIV Cure in the News: The South African child - Maria Paximadis, University of the Witwatersrand and National Institute for Communicable Diseases (Cell Biology), South Africa
- The San Francisco and Esperanza patients - Gabriela Turk, University of Buenos Aires, Argentina
- Exceptional HIV Elite Controllers - Javier Martinez-Picado, irsiCaixa AIDS Research Institute, Spain
- The Philadelphia patient - Pablo Tebas, University of Pennsylvania, USA
- amfAR-UCSF HIV Cure Trial - Michael Peluso, University of California, San Francisco, USA
- Considerations for cis-Women in HIV Cure Research - Jessica Prodger, Western University, Canada
- End of life research - Caroline Dufour, Université de Montréal, Canada
- The Last Gift Update - Jeff Taylor, University of California AntiViral Research Center, USA
- Virology of the reservoir - Zabrina Brumme, Simon Fraser University, Canada
- Broadly neutralizing antibodies and the HIV reservoir - Christian Gaebler, The Rockefeller University, USA
- Landscape analysis & diversifying efforts - Elizabeth Barr, National Institutes of Health, USA
- SHIV Reservoirs Persist Following CAR T Cell-Mediated Depletion of B Cell Follicles in Nonhuman Primates - Chris Peterson, Fred Hutch Cancer Center, USA
- Block, Lock, & Excise - Lishomwa Ndhlovu, Weill Cornell Medicine, USA
- HIV reactivation from latency using a Tat compound - Marion Pardons, Ghent University, Belgium
- The FRESH Cohort: 10 years of Acute HIV Research in South Africa - Krista Dong, iTeach, South Africa
- Sunnylands Retreat 2022: Ensuring Accessibility of Gene Therapy- Based Cures for HIV and Sickle Cell Disease - Sharon Lewin, IAS & The Peter Doherty Institute for Infection and Immunity, Australia